CRISPR-Cas9 has gone from obscure bacterial immune system to Nobel Prize–winning genome editing platform in barely a decade. To use it well, you need to understand the mechanism.
The biological origin
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a bacterial adaptive immune system. When bacteria encounter a virus, they store fragments of viral DNA in their CRISPR locus and use those fragments as memory to destroy the virus on re-infection. The Cas9 protein is the molecular scissor, guided by an RNA molecule transcribed from the stored memory.
Step 1: Target recognition
The engineered system uses a single guide RNA (sgRNA) — a chimera of the natural crRNA and tracrRNA — about 100 nucleotides long. The first ~20 nucleotides match your target genomic site. Cas9 binds the sgRNA, scans the genome, and looks for two things:
- A protospacer adjacent motif (PAM) sequence immediately 3′ of the target. For Streptococcus pyogenes Cas9, the PAM is NGG.
- Sequence complementarity between the sgRNA and the DNA strand opposite the PAM.
No PAM, no cutting. This is why PAM availability constrains where you can edit.
Step 2: DNA cutting
Once Cas9 confirms the match, two nuclease domains (RuvC and HNH) each cleave one strand, producing a blunt double-strand break (DSB) typically 3 bp upstream of the PAM. The cell now has a problem: a broken chromosome.
Step 3: DNA repair (where editing actually happens)
Cas9 just makes the cut. The cell determines the edit through one of two main repair pathways:
Non-homologous end joining (NHEJ)
The cell ligates broken ends together, often introducing small insertions or deletions (indels). These indels frequently shift the reading frame, knocking out the gene. NHEJ is active throughout the cell cycle and is the dominant pathway in most cells. It’s the basis of CRISPR knockouts.
Homology-directed repair (HDR)
If a homologous DNA template is present, the cell can use it to repair with high fidelity. By providing a synthetic donor DNA, you can introduce precise edits — point mutations, knock-ins, tag insertions. HDR only works in dividing cells (S/G2 phase) and is inefficient (typically under 10%).
Why this matters for your experiment
If you want a knockout, NHEJ is your friend — design sgRNAs that target early exons and rely on frameshifts. If you want a precise edit, you’ll need HDR conditions: donor template, cell-cycle synchronization, and ideally an HDR enhancer or NHEJ inhibitor.
Beyond Cas9: variants you should know
- Cas12a (Cpf1): Different PAM (TTTV), staggered cut, processes its own crRNA.
- Base editors: Catalytically impaired Cas9 fused to a deaminase — converts one base to another without DSB.
- Prime editors: Cas9 nickase fused to reverse transcriptase, enables targeted insertions and substitutions without DSB or donor DNA.
- dCas9: Catalytically dead Cas9 used for CRISPRi (gene repression) and CRISPRa (gene activation).
CRISPR-Cas9 looks simple from 30,000 feet — RNA finds DNA, protein cuts it. The details of PAM availability, repair pathway choice, and cell-cycle context determine whether your experiment works.
